Related references
Note: Only part of the references are listed.CD133+ melanoma subpopulation acquired resistance to caffeic acid phenethyl ester-induced apoptosis is attributed to the elevated expression of ABCB5: Significance for melanoma treatment
Abdelouahid El-Khattouti et al.
CANCER LETTERS (2015)
Targeting ALDH1 to decrease tumorigenicity, growth and metastasis of human melanoma
Lili Yue et al.
MELANOMA RESEARCH (2015)
Factors Influencing the CNS Distribution of a Novel MEK-1/2 Inhibitor: Implications for Combination Therapy for Melanoma Brain Metastases
Shruthi Vaidhyanathan et al.
DRUG METABOLISM AND DISPOSITION (2014)
MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study
Paolo A. Ascierto et al.
LANCET ONCOLOGY (2013)
Mechanisms Limiting Distribution of the Threonine-Protein Kinase B-RaFV600E Inhibitor Dabrafenib to the Brain: Implications for the Treatment of Melanoma Brain Metastases
Rajendar K. Mittapalli et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Tumor Cell Vasculogenic Mimicry From Controversy to Therapeutic Promise
Richard E. B. Seftor et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
CD133+ Melanoma Subpopulations Contribute to Perivascular Niche Morphogenesis and Tumorigenicity through Vasculogenic Mimicry
Chiou-Yan Lai et al.
CANCER RESEARCH (2012)
Molecular Pathways: Vasculogenic Mimicry in Tumor Cells: Diagnostic and Therapeutic Implications
Dawn A. Kirschmann et al.
CLINICAL CANCER RESEARCH (2012)
Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma
Bhuvnesh K. Sharma et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Tumor Cell Plasticity and Angiogenesis in Human Melanomas
Daniela Mihic-Probst et al.
PLOS ONE (2012)
ALDH1A Isozymes are Markers of Human Melanoma Stem Cells and Potential Therapeutic Targets
Yuchun Luo et al.
STEM CELLS (2012)
VEGFR-1 Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor Growth
Natasha Y. Frank et al.
CANCER RESEARCH (2011)
Human CD271-Positive Melanoma Stem Cells Associated with Metastasis Establish Tumor Heterogeneity and Long-term Growth
Gianluca Civenni et al.
CANCER RESEARCH (2011)
Epigenetic reprogramming as a key contributor to melanocyte malignant transformation
Fernanda Molognoni et al.
EPIGENETICS (2011)
From Cancer Stem Cells to Tumor Maintenance in Melanoma
Mizuho Fukunaga-Kalabis et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Epigenetic Regulation of MicroRNA Genes and the Role of miR-34b in Cell Invasion and Motility in Human Melanoma
Joseph Mazar et al.
PLOS ONE (2011)
Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically Organized
Elsa Quintana et al.
CANCER CELL (2010)
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
Ting-Chao Chou
CANCER RESEARCH (2010)
A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
Alexander Roesch et al.
CELL (2010)
The In Vitro Spheroid Melanoma Cell Culture Assay: Cues on Tumor Initiation?
Tobias Schatton et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Overexpression of CD133 Promotes Drug Resistance in C6 Glioma Cells
James M. Angelastro et al.
MOLECULAR CANCER RESEARCH (2010)
Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271
Alexander D. Boiko et al.
NATURE (2010)
Sequestration of E12/E47 and suppression of p27KIP1 play a role in Id2-induced proliferation and tumorigenesis
Valerie A. Trabosh et al.
CARCINOGENESIS (2009)
Natural killer cells kill human melanoma cells with characteristics of cancer stem cells
Gabriella Pietra et al.
INTERNATIONAL IMMUNOLOGY (2009)
Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation
Liqin Zhu et al.
NATURE (2009)
Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment
Fabricio F. Costa et al.
EPIGENOMICS (2009)
Mutant prominin 1 found in patients with macular degeneration disrupts photoreceptor disk morphogenesis in mice (vol 118, pg 2908, 2008)
Zhenglin Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Expression of CD133-1 and CD133-2 in ovarian cancer
G. Ferrandina et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Mutant prominin 1 found in patients with macular degeneration disrupts photoreceptor disk morphogenesis in mice
Zhenglin Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Plasticity of the cancer cell: Implications for epigenetic control of melanoma and other malignancies
George Lipkin
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Identification of cells initiating human melanomas
Tobias Schatton et al.
NATURE (2008)
Efficient tumour formation by single human melanoma cells
Elsa Quintana et al.
NATURE (2008)
Severe retinitis pigmentosa mapped to 4p15 and associated with a novel mutation in the PROM1 gene
Qingjiong Zhang et al.
HUMAN GENETICS (2007)
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer
Patrick C. Hermann et al.
CELL STEM CELL (2007)
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
Catherine A. O'Brien et al.
NATURE (2007)
Identification and expansion of human colon-cancer-initiating cells
Lucia Ricci-Vitiani et al.
NATURE (2007)
Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential
Elena Monzani et al.
EUROPEAN JOURNAL OF CANCER (2007)
Reprogramming metastatic tumour cells with embryonic microenvironments
Mary J. C. Hendrix et al.
NATURE REVIEWS CANCER (2007)
Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells
Atsushi Suetsugi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Clonal persistence and evolution during a decade of recurrent melanoma
Ena Wang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
BRAF mutation predicts sensitivity to MEK inhibition
DB Solit et al.
NATURE (2006)
Melanoma, a tumor based on a mutant stem cell?
James M. Grichnik et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Prospective identification of tumorigenic prostate cancer stem cells
AT Collins et al.
CANCER RESEARCH (2005)
Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment
EA Seftor et al.
CANCER RESEARCH (2005)
Activation of Notch1 signaling is required for β-catenin-mediated human primary melanoma progression
K Balint et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Bcl-2 regulator FKBP38 is activated by Ca2+/calmodulin
F Edlich et al.
EMBO JOURNAL (2005)
Activated leukocyte cell adhesion molecule (ALCAM/CD166): Signaling at the divide of melanoma cell clustering and cell migration?
GWM Swart et al.
CANCER AND METASTASIS REVIEWS (2005)
ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma
NY Frank et al.
CANCER RESEARCH (2005)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
High-throughput microtiter assay for Hoechst 33342 dye uptake
GM Seigel et al.
CYTOTECHNOLOGY (2004)
AC133-2, a novel isoform of human AC133 stem cell antigen
Y Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Expression and functional significance of VE-cadherin in aggressive human melanoma cells: Role in vasculogenic mimicry
MJC Hendrix et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
A frameshift mutation in prominin (mouse)-like 1 causes human retinal degeneration
MA Maw et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
